美國血液技術 HAE 深 滬
已收盤 02-06 16:00:00 美东时间
59.34
-5.680
-8.74%
華盛通- 最 高66.085
- 今 開65.19
- 成交量 202.26万股
- 最 低 59.04
- 昨 收 65.02
- 總市值 27.78亿
- 52周最高 87.32
- 市盈率 靜 17.95
- 換手率 4.32%
- 52周最低 47.315
- 委 比 28.62%
- 總股本 4680.97万
- 歷史最高 142.11
- 量 比 1.78
- 振 幅 10.84%
- 歷史最低 25.98
- 每 手 1
- 風險率 10.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Haemonetics Earnings Call: Strong Core, IVT Drag
Haemonetics (($HAE)) has held its Q3 earnings call. Read on for the main highli...
30分钟前
财报速睇 | 美国血液技术2026财年Q3营收3.39亿美元，同比下降2.7%；归母净利润0.45亿美元，同比增长19.3%
华盛资讯2月7日讯，美国血液技术公布2026财年Q3业绩，公司Q3营收3.39亿美元，同比下降2.7%，归母净利润0.45亿美元，同比增长19.3%。
02-07 08:20
财报速睇 | 美国血液技术 2025财年Q4营收3.39亿美元，同比下降2.7%；归母净利润0.45亿美元，同比增长19.3%
华盛资讯2月6日讯，美国血液技术公布2025财年Q4业绩，公司Q4营收3.39亿美元，同比下降2.7%，归母净利润0.45亿美元，同比增长19.3%。
02-06 15:42
Haemonetics Sees Revenue for 2026 FY is expected to down by -3 to -1% YoY
Haemonetics (NYSE:HAE) sees Revenue for 2026 FY is expected to down by -3 to -1% YoY
02-05 20:25
Earnings Scheduled For February 5, 2026
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
Haemonetics Raises FY2026 Adj EPS Guidance from $4.80-$5.00 to $4.90-$5.00 vs $4.91 Est
Haemonetics (NYSE:HAE) raises FY2026 Adj EPS guidance from $4.80-$5.00 to $4.90-$5.00 vs $4.91 analyst estimate..
02-05 19:06
Insights into Haemonetics Q3 Earnings
Haemonetics (NYSE:HAE) just disclosed its Q3 earnings on Thursday, February 5, ...
02-05 19:06
Haemonetics Q3 Adj. EPS $1.31 Beats $1.25 Estimate, Sales $338.967M Beat $331.616M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.25 by 4.8 percent. This is a 10.08 percent increase over earnings of $1.19 per share from the same
02-05 19:04
Haemonetics meldet für das dritte Quartal einen Umsatz von 56,6 Mio. USD, ein Rückgang um 19,6 Prozent
Haemonetics meldet für das dritte Quartal einen Umsatz von 56,6 Mio. USD, ein Rückgang um 19,6 Prozent Haemonetics hat die Finanzergebnisse für das dritte Quartal (Q3) des Geschäftsjahres 2026 veröffentlicht. Der Umsatz belief sich auf 582,7 Mio. USD. Das bereinigte operative Ergebnis lag bei 169,9
02-05 19:02
Haemonetics Q3 adjusted EPS rises to USD 1.31, up 38 percent
Haemonetics Q3 adjusted EPS rises to USD 1.31, up 38 percent Haemonetics Corporation reported its financial results for the third quarter (Q3) and year-to-date (YTD) of fiscal 2026, ending December 27, 2025. For Q3, the company recorded revenue of USD 339 million, reflecting a decrease of 3 percent.
02-05 19:02
